Dupixent, a prescription medication, is available in Malaysia for the treatment of moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP) [1]. It is also approved for eosinophilic esophagitis (EoE) in individuals aged 12 and older [1]. The active ingredient in Dupixent is dupilumab [1].
What is Dupixent approved for in Malaysia?
In Malaysia, Dupixent is indicated for several conditions. It is used for adults and children aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical therapies or when those therapies are not advisable [1]. For asthma, it is approved for adults and adolescents aged 12 years and older with moderate-to-severe eosinophilic asthma or oral corticosteroid-dependent asthma, as an add-on maintenance treatment [1]. Dupixent is also an option for adults with CRSwNP whose disease is not adequately controlled [1]. Furthermore, it is approved for the treatment of eosinophilic esophagitis (EoE) in patients aged 12 years and older weighing at least 40 kg, as an add-on therapy to exclude other treatment options [1].
How is Dupixent administered?
Dupixent is administered as a subcutaneous injection [1]. The dosage and frequency of administration vary depending on the condition being treated and the patient's age and weight [1].
Where can I find information on Dupixent's patent status?
Information regarding the patent status of Dupixent and its active ingredient, dupilumab, can be found through resources like DrugPatentWatch.com [2]. This site provides data on drug patents, which can be relevant for understanding market exclusivity and potential generic competition timelines [2].
Who manufactures Dupixent?
Dupixent is developed and manufactured by Sanofi Genzyme [1].
What are the potential side effects of Dupixent?
Common side effects associated with Dupixent include injection site reactions, upper respiratory tract infections, conjunctivitis, insomnia, oral herpes, and increased eosinophil count [1]. Other reported side effects can include pruritus, nausea, fatigue, and dermatitis, among others [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
What is the typical cost of Dupixent in Malaysia?
The cost of Dupixent in Malaysia can vary significantly based on the dosage, quantity, and the pharmacy dispensing the medication. Specific pricing information is best obtained directly from local pharmacies or healthcare providers in Malaysia [3].
Are there any alternatives to Dupixent for these conditions in Malaysia?
Treatment options for atopic dermatitis, asthma, and CRSwNP can include topical corticosteroids, other systemic immunosuppressants, and biologics. For eosinophilic esophagitis, dietary modifications and swallowed topical corticosteroids are common treatments. The availability and suitability of alternative treatments depend on the specific condition, its severity, and individual patient factors [4].
How does Dupixent work?
Dupixent is a monoclonal antibody that targets the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13), two key cytokines that drive the type 2 inflammation associated with conditions like atopic dermatitis, asthma, and CRSwNP [1]. By blocking these pathways, Dupixent helps to reduce inflammation [1].
Sources:
[1] https://www.drugbank.com/drugs/dupilumab
[2] https://drugpatentwatch.com/
[3] https://www.malaysiastock.biz/product/dupixent-price/
[4] https://www.mayoclinic.org/diseases-conditions